Henry O. Gosebruch, EVP, Chief Strategy Officer at AbbVie Inc. (ABBV), bought 30,000 shares at $67.28 ($2.0M) on 2019-07-29, disclosed to the SEC on 2019-07-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |